Lv11
34 积分 2021-04-15 加入
Recent advances in prostanoid EP4 antagonists for human disease therapy: Current status and future perspectives
2小时前
已完结
Discovery of DT-9081, a Potent and Orally Bioavailable Small Molecule Antagonist of the EP4 Receptor for the Treatment of Solid Cancers
4小时前
已完结
Discovery of Potent, Orally Bioavailable, and CNS-Penetrant 1,2,3-Triazolopyridinyl Piperazine-Based PARP1-Selective Inhibitors
16天前
已完结
Discovery of YKS-34 , a Highly Selective PDE4B Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis
16天前
已完结
Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7
1个月前
已完结
Synthesis of Alcohols: Streamlined C1 to Cn Hydroxyalkylation through Photoredox Catalysis
1个月前
已完结
Discovery and SAR Studies of Orally Active Somatostatin Receptor Subtype-2 (SSTR2) Agonists for the Treatment of Acromegaly
1个月前
已完结
Structural insights into the activation of somatostatin receptor 2 by cyclic SST analogues
1个月前
已完结
Structures of the endogenous peptide- and selective non-peptide agonist-bound SSTR2 signaling complexes
1个月前
已完结
Plasticity in ligand recognition at somatostatin receptors
1个月前
已完结
皖公网安备34019202002308
